ORCID ID Requirement
Last semester, Emory began a campaign to have all our researchers’ Open Researcher and Contributor IDs (ORCID) linked to Emory University. As a reminder, ORCID is a global not-for-profit organization that offers researchers a unique digital persistent identifier (DPI) that accurately connects you to your scholarly work throughout your career. Getting and using a free ORCID iD can help researchers save time and get credit for their work in funding, publishing, and research reporting workflows. Funding organizations, including the NIH, require ORCID iDs or similar identifiers to apply for and receive federal funds. Establishing and linking your ORCID iD to Emory is required for NIH submissions. To prevent receiving extra emails on this topic, please complete these steps, which take only a few minutes,
ASAP!
Nominate a colleague for a 2023 DOM faculty or staff award
We are pleased to announce that faculty and staff award nominations are now being accepted for the 2022–2023 academic year. Do you know a faculty or staff member who goes above and beyond in their role? Nominate a colleague by Monday, June 16, 2023, to be considered. All award winners will be recognized during the Kathy Griendling Department of Medicine Honors and Awards Celebration this August.
Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II or Phase IIB Awardees
TABA Consulting Services are part of a comprehensive NIH TABA Program, intended to help small businesses identify and address their most pressing product development needs. Learn more
Videos of Chat GPT/AI sessions are on CFDE Knowledge Hub canvas site
The videos for our "Classroom Considerations Around AI/Chat GPT" (February 27, 2023) and "Artificial Intelligence and the Future of Higher Education" (March 24, 2023) sessions can be found on our CFDE Knowledge Hub Canvas site. Click here to sign up.
ATLANTIS Call for Applications for Pre (4) and Post (6) doctoral training slots
Deadline: Thursday, June 15
ATLANTIS is a U2C/TL1 training program that provides funds for trainee costs plus access to valuable professional development programming and active networking opportunities. Join a vibrant group of scientists tackling research problems related and relevant to the disciplines of kidney, urology, or hematology.
2023 Atlanta VA Research Day
Thursday, May 18 | 8 a.m.–3 p.m. | SOM James B. Williams Medical Education Building
2023 Atlanta VA Research Day will celebrate discoveries and emerging medical innovations in veterans' care, recognize VA researchers' accomplishments, and provide learning and networking opportunities for attendees.
Ask RCRA Community Forum
Thursday, May 18 | noon–1 p.m. | Zoom | Register
The Office of Research Compliance and Regulatory Affairs (RCRA) is delighted to invite you to their monthly "Ask RCRA" community forum! Please join for important research compliance information, including regulatory updates and institutional changes in policies and procedures.
Dean’s Distinguished Faculty Lecture and Award
Thursday, May 25 | 5:30 p.m. | James B. Williams Medical Education Building, Room 110 | RSVP by May 18
The 2023 Dean's Distinguished Faculty Lecture and Award recipient is Larry Young. Dr. Young will give his honorary lecture on "The Brain Science of Social Connections: Implications for Health and Society.”
Maximizing Mentorship: Effective Mentoring in All Forms
Friday, May 19 | noon–1 p.m. | Zoom
This session will discuss why mentoring is important and mentoring best practices. The panelists will also discuss potential challenges to establishing and maintaining mentoring relationships and explore alternative mentoring approaches including peer mentoring, group mentoring, and others.
Do you have an upcoming event or educational opportunity?
Funding & Award Opportunities
Injury Prevention Research Center at Emory (IPRCE) Pilot Research Program (PReP)
Deadline: Friday, May 19 (LOI)
The purpose of this Funding Opportunity Announcement (FOA) is to fund pilot grants led by Emory faculty that are community-rooted and address structural drivers of injury-related health inequities. Outcomes of particular interest are violence and overdose. Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research
First available due date: Monday, June 5; Expires: May 8, 2024
The goal of this Notice of Special Interest (NOSI) is to encourage the use of existing cohorts and datasets for well-focused secondary analyses to investigate novel scientific ideas and/or address clinically related issues on: (1) aging changes influencing health across the lifespan (e.g., Alzheimer’s disease and Alzheimer's disease-related dementias (AD/ADRD)), (2) diseases and disabilities in older persons, and/or (3) the changes in basic biology of aging that underlie these impacts on health (the hallmarks of aging). Emergency Award: RADx-®UP Dissemination and Implementation (D&I) Research on COVID-19
Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
Deadlines: Friday, June 9 (LOI); Monday, July 10 (Full application)
The purpose of this Notice of Funding Opportunity (NOFO) is to support dissemination and implementation (D&I) research focused on increasing access to and uptake of coronavirus disease 2019 (COVID-19) testing interventions – with the goal of reducing COVID-19 disparities and promoting health equity among underserved and vulnerable populations. Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
Deadlines: Wednesday, July 19, 2023; 2024; 2025
The purpose of this FOA is to foster investigator-initiated development of highly innovative technologies to address barriers, limitations, or bottlenecks in translational science – particularly for therapeutic development. Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
Deadlines: Wednesday, August 2, 2023; 2024; 2025
The purpose of this reissued Notice of Funding Opportunity (NOFO) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Deadlines: 30 days prior (LOI); Wednesday, September 6 (Full application)
The purpose of this FOA is to invite eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations that experience health disparities. Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
Deadline: Friday, August 25
The purpose of this FOA is to support the research activities during the early-stage careers of independent clinical researchers. Notice of Special Interest (NOSI): Advancing the Science of Geriatric Palliative Care
Deadline: Friday, September 8
The purpose of this FOA is to encourage research grant applications focused on palliative care in geriatric populations.
Would you like assistance reviewing your grant proposal? DOM researchers can request grant writing and editing services from Janet Gross, PhD, on projects including resubmissions, career development awards, and multicenter grants. These services are offered through a cost sharing effort between the DOM and the researcher’s division and must be approved by both.
Arshed Quyyumi (Cardiology) received funding from Novartis Pharmaceuticals Corporation for a project entitled, “A randomized, controlled, multi-center, open-label trial comparing a hospital, post-discharge care pathway involving aggressive LDL-C management that includes inclisiran with usual care versus usual care alone in patients with a recent coronary syndrome.” Varun Phadke (Infectious Diseases) received funding from University of Colorado/Glaxosmithkline Biologicals for a project entitled, “Safety and immunogenicity of Shingrix administered before and after renal transplantation.” Dean Jones (PI) and Xin Hu (Co-I) (Pulmonary) received funding from Social and Scientific Systems - DLH/NIEHS for a project entitled, “Exposomics and breast cancer risk in the sister study.”
Have you or a colleague recently received an award or grant funding?
Recent Notable Publications
Matthew Gardner (Infectious Diseases)
Davis-Gardner ME, Weber JA, Xie J, Pekrun K, Alexander EA, Weisgrau KL, et al. A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors. Front Immunol. 2023 Apr 21;14:1105617. Read more Michael Saenger (General Internal Medicine)
Hammett PJ, Eliacin J, Makris UE, Allen KD, Kerns RD, Heapy A, et al. An analysis of the role of mental health in a randomized trial of a walking intervention for Black Veterans with chronic pain. J Pain. 2023 Jan;24(1):55-67. Read more Vin Tangpricha (Endocrinology)
Pampati S, Dana Flanders W, Zhang Q, Ahmedani BK, Bhasin S, Getahun D, et al. Prevalence of self-inflicted injuries among transgender and gender diverse adolescents and young adults compared to their peers: an examination of interaction with mental health morbidity. Ann Epidemiol. 2023 May;81:40-46.e2. Read more Karan Uppal, Ken H Liu, Xin Hu, Michael Orr, ViLinh Tran, Young-Mi Go, and Dean P Jones (Pulmonary)
Fernandes J, Uppal K, Liu KH, Hu X, Orr M, Tran V, Go YM, Jones DP. Antagonistic interactions in mitochondria ROS signaling responses to manganese. Antioxidants (Basel). 2023 Mar 25;12(4):804. Read more
Have you or a colleague recently published an article?
Jacob Sherman
Lead Research Specialist – Infectious Diseases What is your professional background?
I graduated from the University of St Andrews in 2020 with a Bachelor’s in Molecular Biology. Since September 2020, I have worked as a Research Specialist in Dr. Erin Scherer’s group at the Hope Clinic, becoming a Lead Research Specialist in 2022. In August, I will be starting the Microbiology and Molecular Genetics PhD program at Emory to continue my research career. Which division do you work in? Who is your mentor?
I work in the Division of Infectious Diseases under the mentorship of Dr. Erin Scherer. Briefly describe your research. Why is it important?
I perform assays in the lab to support clinical trials, including for a Hepatitis E vaccine and a Shigella sonnei vaccine. Additionally, I support Dr. Scherer’s research projects with laboratory assays, including a project investigating the evolution of SARS-CoV-2 in immunocompromised hosts and a project aiming to understand how the glycosylation patterns on antibodies elicited during COVID-19 might influence the severity of inflammation during disease. What do you like most about Emory?
I like the friendly and collaborative atmosphere at Emory, with people generally being happy to share expertise, advice, and ideas. What is your favorite movie or TV show?
My favorite movie is currently Everything, Everywhere, All at Once. What do you like to do in your spare time?
I enjoy reading, video games, and spending too much time at thrift stores. What is a fun fact about you?
I used to perform as a drag queen.
DOM RAS is requesting the following timelines for pre-award requests to the Pre-Award Inbox: - Proposals, progress reports, and other support requests: at least two weeks prior to sponsor deadline. Requests made earlier than two weeks are always appreciated.
- Proposals with subrecipients and/or cost share: at least one month prior to the due date.
- Finalized files: at least five business days prior to the sponsor deadline.
"What's Up" is brought to you by Emory University's Department of Medicine Office of Research.
|